Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival

Basal-like breast cancer is an aggressive tumor subtype with poor prognosis. The discovery of underlying mechanisms mediating tumor cell survival, and the development of novel agents to target these pathways, is a priority for patients with basal-like breast cancer. From a functional screen to ident...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Tiong, Kai Hung, Tan, Boon Shing, Choo, Heng Lungh, Chung, Felicia Fei-Lei, Hii, Ling-Wei, Tan, Si Hoey, Khor, Nelson Tze Woei, Wong, Shew Fung, See, Sze-Jia, Tan, Yuen-Fen, Rosli, Rozita, Cheong, Soon-Keng, Leong, Chee-Onn
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2016
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5295378/
https://ncbi.nlm.nih.gov/pubmed/27192118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9328
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires